Blueberries Publicizes DTC Eligibility of its Frequent Shares in the USA

[ad_1]

TORONTO, July 04, 2019 (GLOBE NEWSWIRE) — Blueberries Medical Corp. (CSE: BBM) (OTCQB: BBRRF) (FRA: 1OA) (“Blueberries” or the “Firm“), a number one Latin American licensed producer of medicinal cannabis and cannabis-derived merchandise, is happy to announce that the Firm’s widespread shares, traded in the USA below the image BBRRF, at the moment are eligible for digital clearing and settlement by way of the Depository Belief Firm in the USA.

Dr. Patricio Stocker, CEO of Blueberries commented: “DTC eligibility will permit present and potential Blueberries shareholders extra dependable, cost-efficient, and well timed clearing and settlement for our widespread shares. This can be a key milestone in the direction of growing our market presence in the USA and fascinating with shareholders.”

The Depository Belief Firm (DTC) is a subsidiary of the Depository Belief & Clearing Company and manages the digital clearing and settlement of publicly traded firms. Buying and selling of securities by way of DTC permits for cost-effective clearing and safe settlement, in flip simplifying and accelerating the settlement course of for buyers.

DTC is a member of the U.S. Federal Reserve System, a limited-purpose belief firm below New York State banking legislation, and a registered clearing company with the U.S. Securities and Change Fee.

About Blueberries Medical Corp.
Blueberries is a Latin American licensed producer of naturally grown premium high quality cannabis with its major operations ideally situated within the Bogotá Savannah of central Colombia and operations at present being established in Argentina. The Firm is led by a specialised staff with proprietary experience in agriculture, genetics, extraction, drugs, pharmacology and advertising, Blueberries is absolutely licensed for the cultivation, manufacturing, home distribution, and worldwide export of CBD and THC-based medical cannabis in Colombia. Blueberries’ mixture of main scientific experience, agricultural benefits and distribution preparations has positioned the Firm to develop into a number one worldwide provider of naturally grown, processed, and standardized medicinal-grade cannabis oil extracts and associated merchandise.

Extra details about the Firm is accessible at www.blueberriesmed.com. For extra data, please contact:

Camilo Villalba, Chief Working Officer
Tel: +57.313.483.0131
E-mail: [email protected]

Jessika Angarita, Pacta Relations
Tel: +1 (305) 877 4710
E-mail: [email protected]

Cautionary Be aware Concerning Ahead-Trying Info
This information launch comprises “forward-looking data” and “forward-looking statements” (collectively, “ahead wanting statements”) throughout the that means of the relevant Canadian securities laws. All statements, aside from statements historic reality, are forward-looking statements and are based mostly on expectations, estimates and projections as on the date of this information launch. Any assertion that includes discussions with respect to predictions, expectations, beliefs, plans, projections, aims, assumptions, future occasions or efficiency (usually however not all the time utilizing phrases resembling “expects”, or “doesn’t anticipate”, “is anticipated”, “anticipates” or “doesn’t anticipate”, “plans”, “finances”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such phrases and phrases or stating that sure actions, occasions or outcomes “could” or “might”, “would”, “would possibly” or “will” be taken to happen or be achieved) aren’t statements of historic reality and could also be forward-looking statements.

These forward-looking statements are based mostly on cheap assumptions and estimates of administration of the Firm on the time such statements have been made. Precise future outcomes could differ materially as forward-looking statements contain recognized and unknown dangers, uncertainties and different components which can trigger the precise outcomes, efficiency or achievements of the Firm to materially differ from any future outcomes, efficiency or achievements expressed or implied by such forward-looking statements. Such components, amongst different issues, embody: fluctuations basically macroeconomic situations; fluctuations in securities markets; expectations concerning the dimensions of the Colombian and worldwide medical cannabis market and altering client habits; the power of the Firm to efficiently obtain its enterprise aims; plans for growth; political and social uncertainties; incapacity to acquire enough insurance coverage to cowl dangers and hazards; and the presence of legal guidelines and laws that will impose restrictions on cultivation, manufacturing, distribution and sale of cannabis and cannabis associated merchandise in Colombia or internationally; and worker relations. Though the forward-looking statements contained on this information launch are based mostly upon what administration of the Firm believes, or believed on the time, to be cheap assumptions, the Firm can’t guarantee shareholders that precise outcomes might be in line with such forward-looking statements, as there could also be different components that trigger outcomes to not be as anticipated, estimated or meant. Readers shouldn’t place undue reliance on the forward-looking statements and knowledge contained on this information launch. The Firm assumes no obligation to replace the forward-looking statements of beliefs, opinions, projections, or different components, ought to they modify, besides as required by legislation.

Extra data concerning the Firm, and different dangers and uncertainties regarding the Firm’s enterprise are contained below the heading “Threat Components” within the Firm’s Itemizing Assertion dated January 31, 2019 filed on its issuer profile on SEDAR at www.sedar.com.

No inventory change, securities fee or different regulatory authority has authorized or disapproved the knowledge contained herein.

Get Actual-Time Updates from The Each day Marijuana Observer



[ad_2]

Latest posts